iTeos Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2019 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
iTeos Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2019 to Q2 2024.
  • iTeos Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 36.5M shares, a 2.06% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 36.5M +738K +2.06% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 35.8M +83.1K +0.23% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 35.8M +227K +0.64% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 35.8M +210K +0.59% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 35.8M +207K +0.58% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 35.8M +244K +0.69% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 35.6M +145K +0.41% Dec 31, 2022 10-K 2024-03-06
Q3 2022 35.6M +318K +0.9% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 35.6M +427K +1.22% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 35.5M +416K +1.19% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 35.5M +421K +1.2% Dec 31, 2021 10-K 2023-03-15
Q3 2021 35.3M +213K +0.61% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 35.1M +34.8M +8949% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 35.1M Mar 31, 2021 10-Q 2021-05-13
Q4 2020 35M +34.8M +13560% Dec 31, 2020 10-K 2022-03-23
Q3 2020 35M Sep 30, 2020 10-Q 2020-11-12
Q2 2020 388K Jun 30, 2020 10-Q 2020-09-01
Q4 2019 257K Dec 31, 2019 10-K 2021-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.